SE381046B - Forfarande for framstellning av 1,4-bensodiazepinderivat - Google Patents

Forfarande for framstellning av 1,4-bensodiazepinderivat

Info

Publication number
SE381046B
SE381046B SE7011828A SE1182870A SE381046B SE 381046 B SE381046 B SE 381046B SE 7011828 A SE7011828 A SE 7011828A SE 1182870 A SE1182870 A SE 1182870A SE 381046 B SE381046 B SE 381046B
Authority
SE
Sweden
Prior art keywords
procedure
preparation
benzodiazepine derivatives
benzodiazepine
derivatives
Prior art date
Application number
SE7011828A
Other languages
English (en)
Inventor
K Meguro
H Tawada
Y Kuwada
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of SE381046B publication Critical patent/SE381046B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/20—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7011828A 1969-09-01 1970-08-31 Forfarande for framstellning av 1,4-bensodiazepinderivat SE381046B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6915369 1969-09-01

Publications (1)

Publication Number Publication Date
SE381046B true SE381046B (sv) 1975-11-24

Family

ID=13394422

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7011828A SE381046B (sv) 1969-09-01 1970-08-31 Forfarande for framstellning av 1,4-bensodiazepinderivat

Country Status (8)

Country Link
US (1) US3795673A (sv)
CH (1) CH532061A (sv)
DE (1) DE2042758A1 (sv)
DK (1) DK124481B (sv)
FR (1) FR2060740A5 (sv)
GB (1) GB1329464A (sv)
NL (1) NL7012813A (sv)
SE (1) SE381046B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4755508A (en) * 1984-06-26 1988-07-05 Merck & Co., Inc. Benzodiazepine analogs and use as antogonists of gastrin and cholecystokinin
US7160880B1 (en) 1999-05-14 2007-01-09 Cenes Limited Short-acting benzodiazepines
PL2081921T3 (pl) 2006-07-10 2011-03-31 Paion Uk Ltd Krótko działające sole benzodiazepiny i ich formy polimorficzne
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión

Also Published As

Publication number Publication date
GB1329464A (en) 1973-09-12
US3795673A (en) 1974-03-05
DE2042758A1 (de) 1971-03-11
NL7012813A (sv) 1971-03-03
CH532061A (de) 1972-12-31
DK124481B (da) 1972-10-23
FR2060740A5 (sv) 1971-06-18

Similar Documents

Publication Publication Date Title
SE382459B (sv) Forfarande for framstellning av xantonderivat.
SE384211B (sv) Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
SE414497B (sv) Forfarande for framstellning av p-karbonyloxim-fenoxialkyl-karboxamider
SE399427B (sv) Forfarande for framstellning av 2,4 diamino-bensylpyrimidiner
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE7511680L (sv) Forfarande for framstellning av furanderivat
SE402451B (sv) Forfarande for framstellning av 14-desoxi-14-acetoximutilin
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE384685B (sv) Forfarande for framstellning av linkomycinderivat
FI52216C (sv) Förfarande för framställning av gamma-piperidinobutyrofenonderivat.
SE416201B (sv) Foerfarande foer framstaellning av 1,4-bensodiazepinderivat
SE381046B (sv) Forfarande for framstellning av 1,4-bensodiazepinderivat
SE400086B (sv) Forfarande for framstellning av acylerade n(6)- aralkyl-adenosin-derivat
SE396599B (sv) Forfarande for framstellning av 1,2-di-substituerade hydraziner
NO136538C (no) Fremgangsm}te for fremstilling av indolderivater
SE394668B (sv) Forfarande for framstellning av 2-etylhexan-1-al
NO137050C (no) Fremgangsm}te til fremstilling av butyrofenonderivater
SE398878B (sv) Forfarande for framstellning av substituerade 2,4-diamino-5-bensylpyrimidiner
DK137454B (da) Fremgangsmade til fremstilling af 1,4-benzodiazepinderivater
SE408302B (sv) Forfarande for framstellning av 1,4-bensodiazepin-derivat
SE388197B (sv) Forfarande for framstellning av 1,4-bensodiazepinderivat
SE414306B (sv) Forfarande for framstellning av 1,4-bensodiazepiner
SE404606B (sv) Forfarande for framstellning av 3-metylhalogen-cefalosporinforeningar
SE392617B (sv) Forfarande for framstellning av 1,4-bensodiazepinderivat
SE386170B (sv) Forfarande for framstellning av 1,4-bensodiazepinderivat